Showing results (11-20 of 120) with videos related to

Sort By:
Pageof 12
The Israel Medical Association Journal : IMAJ|October 9, 2010
Breast cancer HER2 equivocal cases: is there an alternative to FISH testing? A pilot study using two different antibodies sequentiallyAdy Yosepovich, Camila Avivi, Jair Bar, et al.
Acta Oncologica (Stockholm, Sweden)|August 11, 2021
Thyroid dysfunction and survival in cancer patients treated with immune checkpoint inhibitors: analyses from a large single tertiary cancer center databaseRuth Percik, Yair Liel, Damien Urban, et al.
Cancer Reports (Hoboken, N.J.)|August 12, 2025
Real-World Response and Survival Outcomes and Treatment Patterns in Patients With Extensive Stage Small-Cell Lung Cancer Receiving Third-Line TreatmentJair Bar, Qingqing Xu, Sudeep Karve, et al.
Melanoma Research|May 21, 2009
Germline analysis of thymidine/guanidine polymorphism at position 309 of the Mdm2 promoter in malignant melanoma patientsIris Gluck, Amos J Simon, Raphael Catane, et al.
Plos One|February 18, 2026
Rapidly progressive arthropathy identified on imaging of patients treated with Crizotinib for ALK-rearranged/ROS1-positive non small cell lung cancer: A retrospective single-center studyYael Eshet, Liran Domachevsky, Noam Tau, et al.
Cancer Management and Research|February 6, 2020
Self-reported sleep quality as prognostic for survival in lung cancer patientsTeodor Gottfried, Iris Kamer, Iris Salant, et al.
Cancer Research|January 9, 2003
Nuclear factor-kappaB protects the liver against genotoxic stress and functions independently of p53Iris Lavon, Eli Pikarsky, Elena Gutkovich, et al.
Lung Cancer (Amsterdam, Netherlands)|February 16, 2015
Preferences for disclosure of disease related information among thoracic cancer patientsTal Sella, Dana Botser, Rossie Navon, et al.
The Israel Medical Association Journal : IMAJ|December 31, 2020
Early Blood-based Liquid Biopsy in Patients with Treatment-naïve Metastatic Adenocarcinoma of the Lung: A Case SeriesMichael Peled, Jair Bar, Liat Avni, et al.
Oncology Reports|November 21, 2008
Concurrent chemobiotherapy with cisplatin, dacarbazine, decrescendo interleukin-2 and interferon alpha2b in patients with metastatic melanomaJair Bar, Rinat Yerushalmi, Roni Shapira-Frummer, et al.
Pageof 12